0001079973-11-000999.txt : 20111215 0001079973-11-000999.hdr.sgml : 20111215 20111215160207 ACCESSION NUMBER: 0001079973-11-000999 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20111215 DATE AS OF CHANGE: 20111215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-158555 FILM NUMBER: 111263499 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 424B3 1 pure_424b3-121511.htm 424B3 pure_424b3-121511.htm
Filed Pursuant to Rule 424(b)(3)
Registration No. 333 – 158555
Registration No. 333-173826
PROSPECTUS SUPPLEMENT
(to the prospectus dated May 5, 2009)



Up to $7,000,000 in Shares of Common Stock

 
This prospectus supplement amends and supplements the prospectus supplement dated April 29, 2011 and its accompanying prospectus dated May 5, 2009, related to our Sales Agreement with C.K. Cooper & Company, Inc. (“CKCC”), dated April 29, 2011 (the “Sales Agreement”), pursuant to which CKCC has acted as our agent to sell up to $7,000,000 in aggregate amount of shares of our common stock, par value $0.01 per share (“Common Stock”), in “at the market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended.  This prospectus supplement should be read together with the prospectus and prospectus supplement to which it relates.
 
Effective December 14, 2011, we terminated the Sales Agreement and, pursuant to such termination, there will be no future sales of our Common Stock under the Sales Agreement. As of the effective date of the termination of the Sales Agreement, we had sold 3,973,664 shares of our Common Stock under the Sales Agreement for aggregate gross proceeds of $4,326,000, less aggregate commissions of $195,000 to CKCC and other fees and expenses, for aggregate net proceeds to us of approximately $4,130,000.
 
As of December 14, 2011, the maximum aggregate gross proceeds from potential future sales of our Common Stock available under our Registration Statement on Form S-3 (Registration No. 333-158555), together with our Registration Statement on Form S-3MEF (Registration No. 333-173826) was $2,674,340.
 

 

 
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
 


 

 
The date of this prospectus supplement is December 15, 2011.


 
 

 

GRAPHIC 2 logo1.jpg begin 644 logo1.jpg M_]C_X``02D9)1@`!`0$`2`!(``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`!A`-@#`2(``A$!`Q$!_\0` M'``!``(#`0$!``````````````4'!`8(`P$"_\0`41```0,#`@,$!`<)"PP# M`````0(#!``%$08A!Q(Q$T%180@B,G$4%192@9&A(T)6V:=0GYP MPH?XT!.4KPAS(\UKM(KJ'49P2D]#X$=QKWH!2E*`4I2@%*4H!2E*`4I2@%*4 MH!2E*`4I2@%*4H!2E*`5^75\B"H(4LC[U/4U^J4!`R[?=KD2EZX"WQS_`+*( MGF<(\W%;?0$_748YP]M3P_?,NZ/*^&<>ZL.-Q#U#/LFG]&Z'M\B1/C6YB.XI"4\Q[-M*%+))Y4(S]\ MK;?&,[F\L*3A&Q/L_P!CG_W"*LE5KNO#U.EGYT1AP(>DL-K/1*W`"?H)K(0M M*T!2%!23T(.0:YK7PDXF3D]M+O-I2XKUNR1Y48?*)3"?94#T<1G?E.#MU!&/`GGSB-,E.\ M1+JPY)?6PF[I2&RLE(';IVQX5KJQ7.4HR>FB=N9&$(3CW4GH[!I3OH:JET^% M20<%0!\S7Q+B%(YTK24'[X':N??2/F2HVJ;0B/)>:0N(2I*%E()"S@_::]H+ MSL;T3H#T=Q;3R4,D+0H@@_#4]]6_A?DA+?U/12^,W.R&OH6R_`XA2BE*DE0` M)`.XS6--N$.$E2IG8@=WC5="]:Y MXK7Z1$T^KX/%9_AG%.EIB.#N`M:1S*4?FI^H#)K7#%Y;EO45YFR>6X:AQW-^ M1TC(O]IC.!M^XQ4.'H"X*RHEQB3&%/0I+,IM)P3'6'-_#:J$3Z/5Q<2')< M?"#@G%JYD@^&2[D^_:M*U5I35G#6Y1K@_+462KLV+M`<6D!1.R'$GV2<#8Y2 MY;@+SI]Z00D?6:@ M;AIO4JLN,7^+(<[D/15-@_E!2L?56'P=U_\`+.V/QKAV;=[@\HD)1L'D*]EU M(\#@@CN(\Q5BU4G!PDXR\47:[(VQ4X^#*:D7>Y6^>8=[B*B3`.9+C9V4.Y25 M#J*W#0^J5W&4Y;9Z@I](*F7>A<2.H/GW^8]U2FN[0W==/R,I'PB,DOLKQN"! MDCZ0,?5X56>F^T8U+;'DA2"IY`R?FDX/V$U$F-51TP?AC:`E*$/K"<>\UMW! M1I2-)R'5#9Z:XM/F`E"?UI-:/Q`N`DO_'QG^BF_[1ZKTX6_R9:1_H>' M_8HKI9,FL:M'*Q(IY5TO-:-H/2HW4%GAZ@LDVU7-OM8$V4U"B/27U8:905J/D!7-6]]CJ/6NYR=P@E2+%Q=LK+CG*77'[9*`^ M_P#540/SC:34=Q!_E,N_]-)_MTU*<-(JKWQMM9:!4AB3(N3ZDG(2D)4`K/@7 M%I'TU$<2G!%XB7YY[*4-78.K\DAU*L_5O7?_`%I??B>;7^/7]N9V77VO@(.X M((.^:^DUP#TISIZ2_P#&VR_\FK_S-9+/\T>'^+9_]U-87I(NMNZNMB4.)*V8 MO(I(Z@E1)S]!3]?E6:S_`#1X?XMG_P!U-=?]*GW1Q(O=V1[?Z(7T;[,S[H['.LT]4QN-.:4RIQ;*5=F2-E M@`G=)P1ML0*V/]R#0'X+V_\`K?XUY2>$_#N*PMY_3-O0T@94HA6WVU44L??9 M,ONO)UWFM>WY*,X*3'+=QC5PY; M/&H^`'4U5+9)JC_]V``J7H!2E*`5'W*]6JUK0BYW M.#"6X"4)D2$-E0'4CF(S4A7X`\J>YA[\B&^5^FOPAL_Z:U^U3Y7Z:_"*S_IK M7[536/*F/*I;B1^?[_M^3ESTAKA"N6M&G[=,C2V?BQ">TCNI<3GG>VR#UW%7 M+PVU/8(O#K2K$F^6IEYNTQ$+;J\ M^%W\F6D2?]SPS_V45?RM="LYN)R^(NU]T8VI.(^FK)!;DFZ1)H6YV7)$>2ZH M'E4H$A))`]7&?$BJ5XA<87]5$V+3#)2'SR**G4H)SXJ)"4#Q4HC`[AUJY-23 MM&:GMZ(U^:1<8+3O;`.1G5-A:0I/-D#&P*A]=2MH>TW9;-$59F8,*W2G@RRF M''#:%N%7+CE2.N00<^%5ZK:ZERX[9:NILM^5RU'V*_X-VC3&AK4^_<-2V*1? MIP293J)K?*VD>RTC)]D;Y/>?<,5_QXMD!>H']1V2XVZY09:$B:S&E-N.LK2` MGG"`CDO7JY,:;!N&H[Y$GW:XMJ>?:ANI M>:A@+]5D*03D@';IOTJ^ MK;J&VW"88C#RT2P,]@^RMES'CRK`/_Y7Q>HK6B+,E+E!+$1XQWEE!]582%8Z M>"A699CDHIKZ7L0P5!S:?U+3*`]&2]VJ#=]6.S[E$B-NM0@A4EY+7.1VV<AI/$EO2&M].KMT MC4UGCRFU!Z)*3,:)9='?CFW202".\'QP1SI&O5ZX=7XN,SX\=\C!D1'DR8DI M`/?C(QY*`4,]U=C-W&*Y7[:V4Y723CK:?DS5?A]:2GO4EYHI^V^D/&,4&?#CJ5N*(2D?23W#K5^W*%HN,W'F MS;79UB2?N3H@H<+A\L))-25LOUID/,08!=!5E*$"*XVE(`)ZE(`&U3615%\H M5]R+Q+9KC.S:-!X16O2>@K*XEW4UCE7F:4KFR43&PDD#U6T#.0A.3C.Y))., MX%A1]4:?DO)9C7RUO.J]EMN6VI1]P!R:R[G<8EL8[:<\AI!V2#NI1\$@;D^0 MK5)[5_U4OLF4KLUH)W<='W=P>2.[Z?MJK*?-N4O$M0@X)16M(U/7^K4SIWQ; M`?8;4X>3M'GDM(2/-1(`\36PZ'5I'3$$_P"<5E>N+P';R/AC6_\`PI];9(^W MJ?+;-.Z?M^GX9CVUCDYCEQQ>[CI\5*[_`-0[JEL>0J*UYDWR\B$^5^FOPAL_ MZ:U^U61`U%9+A*3&@7BVRI"@2EIB4A:SC0H!O3:,+EYL^TI2L$Q2 ME*`4-*4!R[Z3LN.QKYA+S[2%&U-X2I8!_A'NZKZX6;\,M(8W'Q/#_L45.2[9 M!F.!R7"BON`!6IQU79.S?U%;Z+DR$:<8#.H[9`;#CV&'F4K4G[JOD2)'A,!F&PU'93T;:0$)'T#:@*[@N*:TFIVV7ZVR[.AM6(MRCH!*` M=TJ4%8_J]]?NVW%I&IM.3KE';@Q9%K4W&1R\C;3I*=DYZ>J/>`L#QK=UV.U+ ME_"UVR"J5GF[8QT%>?'FQG-94N*Q,84Q+9;?95[3;J`I)]X-`:_=)5HE:FM# M`8$ZZ-E2VU,N?Z,C&ZUX/L]PSU)QWUI4U:?DEJP@I/\`EI8W.V>S;VZU:4"W MP[CS)7 MPQCMM66=QHNI!:;CI2I>2!R`]J<$].G?6OQ+2[<)^HIMK<2W>(-T6IA><\]]8J[-;%S?AB[="5+SS M=N6$%S/CS8S0&A714=%ITJJVLFU1U3"MA,K*NS!5GG4"H'!]K&>^MGM,N0JY M,(D:FMBT,I21MCJ!YT!ZMPX[;Y>0R@/D8+A&5$>&>M>]*4`I2E`*4I0 M"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E '`*4I0'__V3\_ ` end